Anti-CD19 Antibody (Denintuzumab)
Catalog No.
F1159
Anti-CD19 Antibody (Denintuzumab)
Featured Products
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody portion of an antibody-conjugated active molecule (ADC antibody) to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the study of acute lymphoblastic leukemia.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1630074-14-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Denintuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P15391
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD19
Please avoid freeze-thaw cycles.